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Abstract   
Graphene oxide (GO) has been attracting tremendous attention in the past few years in various 
biomedical applications including; tissue engineering, cell culture, biosensing, bioimaging and 
therapeutics delivery due to unique features it possesses. In this thesis, we demonstrate the 
preparation of crumpled GO functionalized with polyethyleneimine (PEI) (CGO-PEI) via surface 
acoustic waves (SAW) to develop a nanotherapeutic delivery platform with efficient cellular uptake 
and good biocompatibility. Using the SAW, CGO and CGO-PEI of nano-sized range (307.5±11.8 nm and 
281.9±23.3 nm; respectively) were obtained. Functionalization of GO with PEI was successful as 
indicated by Fourier-transform infrared spectroscopy (FT-IR) and thermogravimetric analysis (TGA) 
showing that PEI represents 23% of the total weight. After functionalization and nebulization, GO 
maintained its characteristics as provided by Raman. Finally, we found that functionalizing GO with 
PEI and crumpling it, have reduced the cytotoxicity accompanying PEI more than GO-PEI sheets from 
~18% and ~70% to ~97% in comparison to PEI and GO-PEI sheets; respectively. As well as the PEI-
functionalization has enhanced GO’s cellular uptake by about 1.5 times. These results indicate that 
SAW have the potential to provide CGO-PEI as a nanotherapeutic delivery platform encapsulating 
biological and delicate therapeutics for treatment of various diseases such as cancer and genetic 
disorders in the future.  
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Thesis overview 
The thesis is divided into four chapters including; introduction and literature review followed by 
methodology and materials used in experiments, then results obtained and finally discussion on 
results obtained and the conclusions drawn. More precisely Chapter 1 gives an introduction and 
literature review on GO (graphene oxide) sheets and how they became attractive to be used in various 
applications as a result of the associated unique properties and how those properties are improved 
upon crumpling GO sheets. Then the method used for crumpling GO sheets was discussed in detail 
with elaboration of limitations accompanying the published techniques suggesting that it can be 
overcome by using SAWs (surface acoustic waves) platform instead. Followingly, the SAWs platform 
was described in terms of how it works and how it can be used for particles preparation to use it in 
the preparation of CGO (crumpled graphene oxide). Thus, the aim of the project was to demonstrate 
the capability of SAWs platform to produce CGO as a nanotherapeutic delivery platform that can 
encapsulate delicate therapeutics in one-step as an easy, rapid and low-cost preparation method.   
Chapter 2 includes the materials and methodology used in different experiments of the project 
including various equipment utilized for characterization and examination of the obtained product. 
The results acquired were clearly presented in Chapter 3 with brief explanation under each figure. 
Eventually, the results obtained were all discussed in Chapter 4 to compare it with what was expected 
as well as what has been published in the same field, followed by the conclusion drawn indicating that 
the aim of the project was achieved successfully. In the end, future perspectives for the obtained 
nanotherapeutic platform were addressed for further recommended optimisations and applications. 
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Chapter 1: Literature review and introduction  
1. Graphene-based nanomaterials (GNMs) 
The appearance of graphene in 2004 was accompanied with enormous scientific attention directed 
towards this new material for therapeutics delivery applications [1]. Graphene is a one-atomic thick 
single layer of sp2-hybridized carbon atoms of a π-conjugated structure of six-atom aromatic rings 
arranged in a honeycomb 2D (two-dimensional) crystal lattice. Owing to its unique geometry and 
structure, outstanding physicochemical properties are possessed by the graphene including; large 
specific surface area [1-3], outstanding mechanical strength [4], high electronic properties due to fast 
mobility of charge carriers [5, 6] and excellent thermal and electrical conductivity [7, 8]. Possessing 
these properties has given graphene the edge to be considered as an ideal material for a wide range 
of applications including; nanoelectronics, catalysis, energy applications, quantum physics and 
biomedical applications [9-12].  
For biomedical applications, graphene and its composites have provided new biomaterials that have 
been involved in various applications including; therapeutics delivery, biosensors as well as cell and 
biological imaging [12-16]. Graphene is considered to be a basic building block of various graphitic 
materials with different geometries such as 0D (zero-dimensional) fullerenes, 1D (one-dimensional) 
carbon nanotubes (CNTs) and 3D (three-dimensional) graphite (Fig 1) [1].  
<Image removed due to copyright restrictions> 
Figure 1. Graphene a building block of other carbon materials. It can be wrapped into a spherical structure like 
fullerenes (0D), rolled into CNTs (1D) or stacked into layered structure of graphite (3D). The Figure is retrieved 
from Figure 1 in  [17]. 
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2. Graphene oxide (GO) as a nanotherapeutic delivery platform 
Graphene has been a valuable material for scientists in nanomedicine and biomedical applications due 
to being planar in structure as this provides the magnificent capability of immobilizing enormous 
number of substances including; drugs, fluorescent probes, biomolecules, cells and metals [12-16, 18]. 
According to this magnificent feature graphene can serve as an attractive drug delivery platform for 
gene/anticancer delivery, antibacterial applications, bioimaging, biosensing, tissue engineering and 
cell culture [13, 14, 18-20]. In contrast to CNTs, graphene has the advantage of being large in surface 
area, easy to fabricate and modify, low-cost with the absence of toxic metal particles. This makes 
graphene a threat to dominate CNTs in various applications such as therapeutics delivery [21]. 
Moreover, they are thought to dominate other nanoparticles and therapeutics delivery systems as 
well for possessing a loading ratio of 200%, which is considered to be an outstanding loading capacity 
[22, 23]. This is attributed to the large surface area possessed by graphene (2600 m2g-1) which is four 
folds higher in magnitude than the surface of any other nanomaterials examined in therapeutics 
delivery [24].   
In 2008 Dai’s group was the first to suggest that polyethylene glycol (PEG)-functionalized 
nanographene oxide (NGO) for use as a novel drug nanocarrier to load and deliver anti-cancer drugs 
[25].  Graphene and graphene oxide (GO) has been studied lately as an emerging new and competitive 
therapeutics delivery system for targeting both-local or systemic therapeutics. They have been 
extensively studied since they provide nanotherapeutic drug delivery platform that can be loaded with 
different therapeutics such as antibodies, proteins, DNA, genes and small drug molecules (Fig 2). 
Although graphene and GO possess the same feature that is associated with the outstanding loading 
capacity, GO seem to excel in surface chemistry features since it is hydrophilic and therefore, can be 
dispersed in water and a number of other solvents without the need of surfactants to be used for any 
biological applications [26].   
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<Image removed due to copyright restrictions> 
Figure 2. Schematic diagram for therapeutics that can be carried by graphene and GO to act as a nanotherapeutic 
drug delivery platform. The Figure is retrieved from Figure2 in [17] 
2.1. How is GO prepared?  
GO is an oxygen-decorated graphene sheet usually prepared by Hummer’s method where the graphite 
is oxidized via potassium permanganate (KMnO4) and sulfuric acid (H2SO4) treatment. The reaction 
takes place between graphite and concentrated H2SO4 with sodium nitrate and KMnO4 acting as 
catalysts. This process has been developed in 1958 to be a fast, safe and highly efficient method for 
producing GO. Hummer’s method is considered to be safer in comparison to Staudenmeier’s method 
that involve the use of potassium chlorate that is hazardous associated with explosive risk. Moreover, 
the yield of GO is much higher for Hummer’s method [27]. This method involves weakening the Van 
der Waal interactions between graphene sheets into graphite through an extensive oxidation of the 
aromatic structure followed by their exfoliation and redispersion in solution [26].  
2.2. Surface modification of GO 
The key for obtaining biocompatible drug carriers with a controlled behaviour in the biological system 
is their surface chemistry. Although GO can be dispersed in water, it tends to aggregate in the presence 
of salts found in the physiological buffers caused by the phenomenon of charge masking. Thus, the 
modification of GO to obtain the desired drug carriers is essential. The presence of oxygen-containing 
groups as well as its ease in being soluble in most solvents, makes GO more attractive over graphene 
for functionalization (i.e. surface modification). For surface modification, two methods are mainly 
involved: noncovalent and covalent modification. The covalent modification is usually achieved either 
via interaction with oxygen-containing groups or by atom doping. While the noncovalent modification 
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involves interaction via electrostatic binding or Van der Waal forces. In Table 1, the different 
modifications employed for therapeutic delivery applications have been summarized.  
Table 1. Summary of functionalized GO for therapeutic delivery applications.  
Methods 
Functionalizing Material 
References 
Covalent  
- Chitosan  
- Folic acid (FA)  
- Polysebacic anhydride (PSA) 
- Polyethylene glycol (PEG)  
- Poly (vinyl alcohol) (PVA) 
- Polyacrylic acid (PAA)  
- Polyethyleneimine (PEI)  
- Sulfonic acid  
- Amphiphilic copolymers  
- Poly(N-isopropylacrylamide) (PNIPAM) 
- [28, 29] 
- [30-32] 
- [33] 
- [25, 34-43] 
- [44, 45] 
- [46] 
- [40, 47-51] 
- [32] 
- [52] 
- [53] 
Noncovalent  
- Electrostatic  
- π−π stacking interaction  
- Hydrogen bonding  
- Van der Waals force 
- Coordination bonding  
- [54-58] 
- [59] 
- [56] 
- [60] 
- [61] 
 
2.3. GO modified with PEI (GO-PEI) as an example of delivery platform  
As a nanotherapeutic delivery platform, GO has been studied for the delivery of various therapeutics 
including; small drug molecules [25, 28-32, 35, 36, 58, 62, 63], proteins [64], DNA [65-68] and genes 
[29, 38-40, 47-50, 55].  The development of gene delivery platforms (non-viral gene therapy) has been 
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the concern of both academic world and industry for decades. The justification for all this attention is 
the belief in the potential of this avenue to cure diseases that are difficult to control using traditionally 
available medications.   The challenge is to develop a platform that is clinically safe and efficient in 
gene transfection. Among all materials explored in gene delivery, the cationic polymer 
polyethyleneimine (PEI) has been considered as the ‘golden standard’ for gene transfection. This is 
due to its strong binding to nucleic acids (while protecting them from degradation via nuclease 
enzymes), excellent cellular uptake owing to its positive charge that interacts electrostatically with the 
negatively charged cell surface membrane allowing particle wrapping as well as the endosomal release 
of binding nucleic acids in response to induced proton sponge effect [69-71].  
2.3.1. Challenges associated with GO and PEI to be used in cellular delivery 
Though the proton sponge effect aids in the release of nucleic acid, it induces cell death as the primary 
amines of PEI buffer the protons being pumped into the lysosomes. Accordingly, the pump activity 
gets elevated in response to the PEI’s buffering effect, leading to the accumulation of chloride (Cl-) 
ions and water within the lysosome. This accumulation will eventually cause the osmotic rupture of 
the lysosome [72]. However, membrane thinning and erosion may result from the interaction of high 
density of cationic residues with the cell membrane through the induction of pore formation leading 
cell apoptosis [73]. Thus, its use for gene delivery has been restricted as a consequence to its high 
cytotoxicity and poor biocompatibility, especially of those with the high molecular weight. GO was 
another material on which the scientists focused to be used for gene delivery because of its efficient 
protection against cleavage via the nuclease enzymes inter- and intracellularly just like the PEI [65, 66, 
74, 75]. This is believed to be due to the steric hindrance associated with the complex of nucleic acid 
strongly binding to GO, thus preventing nuclease enzymes-mediated digestion [74].  
Nonetheless, GO has shown to possess of degree of cytotoxicity if delivered solely. In different types 
of cells including; fibroblast or human lung epithelial cells, single-layer GO sheets internalize and gets 
sequestered in cytoplasm within membrane-bound vacuoles such as lysosomes, also gets inside the 
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mitochondria, nucleus and endoplasm [17]. The study conducted by Wang, K., et al. [76] suggest that 
when the GO gets internalized in the previously mentioned organelles of cells, it may result in the 
disturbance of cell energy metabolism where the mitochondrial respiration is increased inducing the 
generation of reactive oxygen species (ROS) that eventually results in cell apoptosis. ROS are 
redundant free radicals that upon accumulation intracellularly, they are resistant to the defensive 
actions-mediated by the cellular antioxidant enzymes such as superoxide dismutase (SOD). As ROS 
accumulate intracellularly, they start to interact with the cell membrane lipids and proteins resulting 
in the membrane’s destruction. Together with the activation of the inflammatory and apoptotic 
pathways, ROS induce apoptosis in cells [60, 77].  
Cell apoptosis is also believed to be induced via GO influence on cell signalling where GO sheets gets 
attached to human cell surface, providing cells with a stimuli signal that is transduced consequently 
to the cells and the nucleus. This signal transduction leads then to down-regulation of adhesion-
associated genes and corresponding adhesive proteins including; fibronectin, laminin, cell cycle 
protein cyclin D3 and focal adhesion kinase (FAK). Down-regulating the production of these proteins 
will result eventually in the decrease of cell adhesion, causing cells to detach, float, and shrink in size 
leading to their death [76, 77]. 
2.3.2. Combining GO with PEI reduces the cytotoxicity associated with each  
Studies were performed to examine the combination of GO and PEI for the aim of developing 
nanotherapeutic delivery platform with enhanced transfection efficiency and reduced cytotoxicity. It 
has been revealed in several studies that GO-PEI hybrid has shown efficient cellular uptake with 
reduced cytotoxicity [48, 49, 55, 78]. It is believed that both GO, and PEI limit the toxicity of each other 
in several ways. PEI-functionalization seems to improve the GO’s stability in physiological environment 
thus, lowering the toxicity resulting from GO agglomeration [55]. PEI-functionalization also allows 
protein binding to the complex’s surface to form protein corona that aids in lowering the cytotoxicity 
of GO [78]. At the same time complexing PEI with GO, lower the density of cationic residues that can 
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interact with the cells thus, minimizing membrane thinning and erosion via hole formation [73]. The 
effect of PEI, GO and GO-PEI on cell viability is summarized in a schematic diagram in Fig 3.   
 
Figure 3. Schematic diagram to explain the effect of PEI, GO and GO-PEI on cell viability. (1) PEI can internalize 
the cell since it is positively charged thus, it can interact favourably with the negatively charged cell membrane. 
However, PEI especially those of high molecular weight induce cytotoxicity via membrane thinning followed by 
erosion as a consequence to membrane-mediated interaction (2) GO can only enter the cell by endocytosis which 
is a concentration-dependent mechanism since it is negatively charged. If it is high in concentration it induces 
cell apoptosis via the release and accumulation of ROS. (3) On the other hand, complexing GO with PEI, enhances 
the GO’s uptake since it is overall charge will be positive and the same time the cytotoxicity of both will be 
reduced. This will be due to the enhanced stabilization of GO and reducing the density of cationic residue of PEI 
to interact with the cell.  
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3. Crumpled GO (CGO) as a nanotherapeutic delivery platform 
3.1. Drawbacks associated with GO sheets and how to overcome them? 
The tendency of graphene sheets to re-stack due to strong π−π interactions hinders efficient aqueous-
based processing and applications. A significant decrease in accessible surface area and aqueous 
stability results from this re-stacking which limits their mass production and industrial applications. 
Separators such as water and carbon nanotubes (CNTs) have been employed to avoid re-staking, but 
its recovery reliability and catalytic durability are not fully guaranteed. In addition to functionalizing 
GO, it was interestingly found that crumpling GO from 2D into 3D structure has shown an outstanding 
compression- and aggregation-resistant properties with the maintenance of high specific surface area 
[79, 80].  
Thus, to enhance stability of GO against collapsing or unfolding, crumpled GO has been developed 
which has large number of π−π stacked folds. Since the crumpled morphology of GO prevents inter-
particle van der Waals attraction, aggregation is also avoided [81]. CGO is characterized by the 
presence of multiple kinks and ridges which are regions of high strain and energy densities. Based on 
published theoretical work the chemical activities of these regions’ atoms seems to be enhanced [82].  
3.2. How CGO is prepared? and associated drawbacks with the crumpling 
technique used 
The most commonly used procedure for the synthesis of CGO is the aerosolization of GO suspension 
via a nebulizer into micrometer-sized droplets along a furnace aerosol reactor with the aid of nitrogen 
(N2) gas for heat exposure to induce crumple formation via evaporation-linked confinement forces 
(Fig 4)[83]. GO sheets dispersions are aerosolized into a mist of droplets that upon solvent evaporation 
the GO sheets start to migrate to the air-liquid interface and then crumple as a result of capillary 
compressive force [80, 83, 84]. Preparation of crumpled GO through aerosolization avoids the impact 
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of the substrate on the thermochemical properties of GO. It excludes the adsorption of gases and 
monolayer films that may affect the crumpled GO’s electron density, bond strength and direction and 
extent of charge transfer [85].  
However, the aerosolization technique used to produce CGO include the use of furnace of 
temperature 200-600ᵒC and nebulization at low frequencies (20-180 kHz). This involves exposing the 
material to aggressive conditions such as elevated temperatures and shear stress. Thus, limiting the 
use of the technique for encapsulation of thermolabile drugs and biological samples such as cells, 
proteins, nucleic acids and antibodies.  It has been mainly studied to encapsulate inorganic 
nanoparticles as shown in the following section.   
3.3. CGO nanocomposites applications  
The specific properties of GO sheets including; thermal, electrical conductivity and electric reactivity 
are enhanced upon crumpling due to lack of sheets re-stacking form the strong π–π interactions.  Since 
CGO has shown to provide outstanding aggregation-resistance. Thus, CGO that is of a higher stability, 
provides larger accessible surface area with improved electrochemical performance in biosensors 
[86], supercapacitors [87] and fuel cell catalysts [88]. In electrocatalysis, they have shown the ability 
to deliver significantly higher electrical conductivity via enhanced electron transfer [87]. In addition to 
enhancing the GO characteristics for various applications, crumpling of GO facilitate controlled 
encapsulation of functional nanoparticles while being intrinsically porous. The structure of CGO 
includes inherent physical such as holes with low valleys and high ridges to provide internal nanoscale 
channels for permeation and transportation of encapsulated material to the surrounding medium.   
Therefore, the development of CGO nanocomposites encapsulating nanoparticles would allow the 
design and manipulation of platform to possess various reactivities including; photoreactivity, surface 
chemistry and antimicrobial activity, specific for targeted applications. Examples of such CGO 
nanocomposites that were published recently, were prepared via aerosolization of GO suspension 
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mixed with either pre-synthesized noble metal nanoparticles [89, 90] or precursor ions [91]. Various 
nanoparticles have been encapsulated including; Pt [92], Si [81], Mn3O4 and SnO2 [91], Au/Fe3O4 [89], 
Fe3O4 [93], Au [94] and TiO2 [95, 96] nanoparticles for electrochemical and optical applications. 
Since CGO provides a semi closed structure that allows facile controlled encapsulation of various drug 
components while remining intrinsically porous which makes them a better candidates as a 
nanotherapeutics delivery platform in comparison to GO [97]. The encapsulation of drugs has been 
recently addressed using CGO so that they can be used for the delivery of both inorganic particles and 
drugs for biomedical applications. For example, Chen YT et al. [89] encapsulated caesium chloride 
(CsCl) known for antineoplastic properties with the addition of carboxymethyl cellulose to provide 
drug delivery nanocomposite platform. Tang et al. [98] also encapsulated doxorubicin-loaded silica 
nanoparticles to provide a platform of controlled drug release manner in response to external stimuli 
mainly light-dependent. Recently published CGO nanocomposites for various applications have been 
summarized in Table 2.  
Table 2. Summary of previously published CGO encapsulating various nanoparticles and materials for different 
applications 
Encapsulated 
materials 
Applications References  
Pt nanoparticles - Enhanced electrocatalysis - [92] 
Pt-Au alloy 
nanoparticles  
- Superior electrocatalysts for methanol fuel cells - [88] 
Si nanoparticles - Enhanced performance of lithium ion batteries - [81] 
Au/Fe3O4 
nanoparticles 
- Enhanced contrast for multimodal bioimaging 
including X-ray computed tomography and magnetic 
- [89] 
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resonance imaging as well as being magnetically 
responsive. 
Fe3O4 
nanoparticles 
- Ultrafast and long cycle-life lithium ion batteries 
- Supercapacitors with high capacitance and electrical 
conductivity 
- Efficient enzyme immobilization while maintaining its 
activity 
- [99] 
- [100] 
- [101] 
Fe2O3 
nanoparticles 
- Improved electrochemical performance for lithium 
ion batteries 
- [102] 
Au 
nanoparticles 
- Intracellular enhanced Raman imaging and drug 
delivery 
- [103] 
TiO2 
nanoparticles 
- Efficient photocatalytic activity via high electronic 
conductivity 
- High catalytic performance for glucose biosensing 
- [104-
106] 
- [95] 
Ag/TiO2 
nanoparticles 
- Advanced water treatment and separation - [80, 
97] 
CoO 
nanocrystals 
- High performance bi-functional electrocatalysts (for 
oxygen reduction and evolution reactions) 
- [107] 
VO2 
nanocrystals  
- A cathode material for lithium ion battery - [108] 
As the aerosolization technique involves the exposure of nebulized materials to harsh conditions 
including; low frequency ultrasonic waves and elevated temperature, it makes it impossible to 
encapsulate thermolabile and biologically-based therapeutics within CGO for various biomedical 
applications. Thus, it was important to find an alternative to this technique to obtain CGO in the 
absence of heat. Based on published studies, crumpling of GO sheets is more related to solvent 
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evaporation rather than exposure to heat [83, 109]. Heating in the aerosolization technique used is 
more involved in changing the chemical composition of the GO i.e. reducing it. For this reason, it was 
thought of using surface acoustic waves (SAW) platform to produce CGO without exposing the 
nebulized material to harsh conditions to allow the encapsulation of thermolabile and biologically-
based therapeutics in the future with inorganic nanoparticles for various biomedical applications.  
<Image removed due to copyright restrictions> 
Figure 4. Ultrasonic nebulization technique for the generation of CGO. The suspension of GO sheets gets nebulized 
by ultrasonic nebulizer to produce a mist of micro-sized droplets. As the droplets fly through the furnace with the 
aid of N2 gas, they get exposed to an elevated temperature of 200-600ᵒC. During flight the droplets start to 
shrink, as a result from solvent evaporation from heat exposure. This will induce the crumpling of the GO sheets 
into ball-like structure in response to capillary compressive force. Eventually all the CGO generated is collected 
on a filter placed at the end of the furnace. The Figure is retrieved from Figure 1 in  [91]. 
4. Surface acoustic waves (SAW) as a nebulization platform for 
particles preparation   
4.1. What are the SAWs?  
SAW are nanometer order sound waves in the non-audible frequency range (10-1000 MHz) like 
earthquake tremors which are generated by mechanically straining of a single crystal piezoelectric 
substrate [110, 111]. These waves are generated through the transduction of electric field in the 
piezoelectric material and their propagation direction is based on the material’s geometry [110]. For 
decades they have been used in telecommunication industry as well as touch-sensitive screens, 
automotive windscreen raindrop sensors and as chemical/biological sensors [112, 113]. Microfluidic 
droplet actuation and manipulation has been an attractive application for SAW. An interlocking comb 
shaped array of metallic electrodes known as interdigital transducer (IDT) electrodes form the SAW 
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device. The distance between the interlocking electrodes determine the frequency of the generated 
sound waves.  
On a piezoelectric material, such as lithium niobate (LiNbO3) the IDTs are patterned using standard 
lithographic techniques and lift-off or wet etching. This piezoelectric material starts to expand and 
contract upon the application of radiofrequency (RF) signal to the IDT because of charges 
redistribution. SAW will be produced as a consequence of this continuous piezoelectric substrate 
deformation. These waves have longitudinal and transverse vibrations along their direction of 
propagation resulting in an elliptical movement of a point near the surface. The direction of this 
elliptical movement is parallel to the wave propagation and perpendicular to the surface. From the 
transducer pitch SAW wavelength can be determined (λ=2d, where d represents the distance between 
two consecutive fingers in IDTs), whereas the central frequency of SAW can be determined from this 
relation: f= C /λ, where C is the wave propagation speed of SAW in the substrate, f and λ are the 
frequency and wavelength of SAW; respectively [110, 114]. Single crystal LiNO3 is preferred in SAW 
microfluidic application due to the relatively high electromechanical coupling coefficient which is 
often expressed as the retained percentage from the total energy after transduction, usually denoted 
by k2. In comparison to quartz, langasite and lithium tantalite, LiNO3 has the highest k2 value of 5.6 
[115].  
4.2. How SAWs can be used for particle preparation? 
When SAW migrates into a sessile droplet placed on piezoelectric substrate surface, it launches into 
the bulk of the fluid. Due to the difference between the speed of SAW within the liquid and on a 
substrate, refraction of the waves results at a certain angle that can be calculated from Snell’s law: θ= 
sin-1 (Cl/Cs) where Cl and Cs are the speeds of sound in the fluid and the substrate; respectively [114, 
116]. This angle is approximately 22ᵒ and known as the Rayleigh angle [117]. Once the waves 
internalize the liquid bulk, they get reflected because of the confining liquid boundaries resulting in 
fluid flow known as acoustic streaming [118, 119]. This acoustic streaming will lead to the internal 
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circulation of the fluid inside the sessile droplet (Fig 5). The Rayleigh wave mainly propagates on the 
device’s surface rather than the bulk; thus, the maximum energy of the material is consequently 
located on the surface.  
<Image removed due to copyright restrictions> 
Figure 5. Schematic diagram showing SAW streaming and fluid circulation inside a droplet. Once the SAW gets 
in contact with droplet placed on the surface of the piezoelectric material, the SAW energy leaks into the droplet 
at the Rayleigh angle of 20ᵒ due to the acoustic impedance mismatch.  The Figure is retrieved from Figure 1 in  
[116]. 
Various fluid actuation phenomena can be generated ranging from drop vibration, motion, jetting and 
atomization under different power loads (Fig 6). At low power, droplet vibration can be utilized for a 
wide range of applications including droplet heating [120], droplet mixing [115] and particle 
concentration and patterning [116] (Fig 6a). Power increase will enhance the acoustic streaming, 
leading to a significant inertial force that will drive the droplet in the wave propagation direction (Fig 
6b). This droplet motion has been utilized for sample collection and dispensing as well as pumping. 
Further increase in the power intensifies the acoustic streaming resulting in droplet jetting into the air 
(Fig 6c) [114] which is suitable for ink-jet printing applications. When a power of a sufficient magnitude 
is applied, atomization of droplet results (Fig 6d).  
Atomization occurs when the capillary stress which depends on the liquid surface tension is overcome 
by SAW resulting in large droplet splitting into an aerosol of micron and sub-micron sized droplets 
[111, 121]. These droplets will result in particles with a narrow size distribution [111]. SAW 
nebulization platform has been used previously for the synthesis of polymeric and protein nano and 
microparticles for targeted delivery and sustained drug release [122, 123]. Characteristics such as 
being rapid, simple (as it does not require auxiliary equipment such as nozzle), of low cost, portable 
and easy to fabricate proffers the SAW platform to be used in fabrication of different types of particles 
for drug encapsulation and delivery [110, 119]. It can be used with biologically-based therapeutics as 
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it involves high frequency-mediated nebulization thus, will not expose material to high shear stress 
that may result in degradation of big molecules such as pDNA or denaturation of protein as a result of 
induced cavitation [110].  
<Image removed due to copyright restrictions> 
Figure 6. Schematic diagram showing the effect of increasing power applied on IDTs on the sessile droplet placed 
on the surface of the piezoelectric substrate. The acoustic streaming generated within the droplet can result in 
droplet a) mixing b) motion c) jetting or d) atomization. The Figure is retrieved from Figure 3 in  [119]. 
4.3. The use of SAWs for the preparation of CGO-PEI 
GO is associated with multiple characteristics that make them attractive to be used as a 
nanotherapeutic delivery platform including; large loading capacity as well as associated optical and 
electronic properties that can be used for bioimaging and biosensing purposes. Those properties are 
further enhanced via crumpling to avoid aggregation and reduction of accessible surface area. Based 
on the previously mentioned explanation of how the SAWs are generated and how could they 
contribute in particles production, it was suggested to use SAWs to produce CGO-PEI without exposing 
the material to harsh conditions such as elevated temperature (as crumpling does not require 
exposure to heat) and low frequency ultrasonic nebulization (as SAWs are ultrasonic sound waves of 
high frequency (10-1000 MHz). Thus, the use of SAWs platform can allow the production of CGO-PEI 
that can concomitantly encapsulate thermolabile and biologically-based therapeutics without 
resulting in their decomposition, degrading or denaturation for various biomedical applications in the 
future.   
In this work we demonstrate the preparation of CGO-PEI using SAWs platform in the absence of heat 
to provide a nanotherapeutic delivery platform that can encapsulate biologically-based and 
thermolabile therapeutics for various biomedical applications such as delivery of gene for cancer or 
genetic disorder treatment and protein such as insulin for diabetes.  To our knowledge this is the first 
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time that SAWs platform is studied to prepare CGO-PEI as well as preparing CGO-PEI at room 
temperature.  
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Thesis scope and objectives 
The main aim for this study to examine the capability of SAWs platform to generate CGO-PEI to provide 
a nanotherapeutic delivery platform that can concomitantly encapsulate thermolabile and biological 
therapeutics during preparation to use them for future biomedical applications. The delivery platform 
should be of efficient cellular uptake and low cytotoxicity.  
Thus, the objectives of this project are: 
1. Prepare CGO from GO sheets of nano-size range using SAW. 
2. Functionalize CGO with a cationic polymer and examine the functionalization effect on the 
cellular uptake and cytotoxicity in comparison to bare CGO. 
3. Examine and compare the effect of crumpling GO-PEI on the cellular uptake and cytotoxicity 
versus GO-PEI sheets.  
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Chapter 2: Materials and Methods 
1. Materials 
Single Layer Graphene Oxide sheets of 300-800nm lateral dimensions were purchased from Cheap 
Tubes Inc. (Cambridgeport, VT, USA). Branched Polyethyleneimine (PEI) of Mwt 25 kDa, N-(3-
Dimethylaminopropyl)-N’-ethyl carbodiimide hydrochloride (EDC), 3-(4, 5-dimethylthiazolyl-2)-2, 5-
diphenyltetrazolium bromide (MTT), Dimethyl sulfoxide (DMSO) and A549 cells were bought from 
Sigma-Aldrich (Darmstadt, Germany). Phosphate buffered saline (PBS), Dulbecco’s modified Eagle’s 
culture medium (DMEM) with Glucose and L-Glutamine, Pen-Strep, and Trypsin EDTA were purchased 
from Lonza (Basel, Switzerland). Fetal Bovine Serum (FBS) was supplied by Life Technologies (Carlsbad, 
CA, USA). Trypan Blue Solution was obtained from Fluka (St. Louis, MO, USA). UltraPure™ 
DNase/RNase-Free Distilled Water, Opti-MEM™ I Reduced Serum Medium, RNase AWAY™ Surface 
Decontaminant Spray, STAT-3 specific siRNA silencer and fluorescently-labelled siRNA (BLOCK-iT™ 
Alexa Fluor™ Red Fluorescent Control) were purchased from ThermoFisher Scientific (Waltham, MA, 
USA).  
2. Methodology 
2.1. Crumpled graphene oxide (CGO) preparation and characterization  
A suspension of 0.5 mg/ml GO sheets was suspended via probe sonicator (Q500 Sonicator, QSonica, 
Newtown, CT, US) in de-ionized (DI) water for 30 mins. This GO suspension was nebulized using a 30 
MHz SAW device at a feeding rate of 50 ml/hr with the aid of a syringe pump as illustrated in Fig 7. GO 
suspension was fed using 5 ml syringe and 30G 1-inch needle. The resulting mist was collected on 
either a substrate or in a 50 ml falcon tube for further analysis. The concentration of collected mist (of 
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nebulized GO) was determined by UV-Vis spectrophotometer (Cary60 UV-Vis, Agilent, Santa Clara, CA, 
US) at a wavelength of 230 nm.  
The SAW device used for the nebulization of GO suspension was made of a 127.86ᵒ Y-X rotated lithium 
niobate (LN) single crystal piezoelectric substrate (Roditi Ltd., London, UK). On this piezoelectric 
substrate interdigitated transducer (IDT) electrodes were photolithographically patterned. To these 
IDTs, alternating electrical signal at resonance of 30 MHz (based on the SAW device used) was applied. 
This power was provided via the aid of a signal generator (SML01, Rhode & Schwarz Pty. Ltd., North 
Ryde, NSW, Australia) and amplifier (10W1000C, Amplifier Research, Souderton, PA, USA) in order to 
provide a power above the critical input power which is usually typically 2-2.5 W. The patterned IDTs 
were elliptical in shape consisting of forty alternating 33- and 66-nm thick chromium-aluminium finger 
pairs. Those IDTs fingers produce a focused SAW with a wavelength of 132 µm that is corresponding 
to the 30 MHz resonant frequency applied (Fig 7).  
Nebulization via SAW device creates micro-sized droplets via the Rayleigh mechanism in which the 
SAW travels along the surface of the piezoelectric substrate (LiNbO3) and leaking within the GO 
suspension fed on the surface from the tip of the syringe needle. This results in acoustic streaming 
within the fluid bulk that overcomes the capillary stress of the fluid, destabilizing it to break into a fine 
mist of droplets [124]. The mean diameter of the obtained droplets was originally estimated from a 
balance between the acoustic and capillary stresses by Rayleigh in 1883:  
𝐷 ~ (
8𝜋𝛾
𝜌𝑓2
)
⅓
(1) 
Where 𝜌 and 𝛾 are the density and the surface tension of the liquid; respectively and f is the acoustic 
radiation frequency. This equation shows that droplet size is directly related to two forces mainly; the 
capillary and acoustic stresses. Since deionized water is the liquid in which the GO sheets are 
suspended, its interfacial tension and density values were substituted in the above equation (71.99 
mN/m and 0.9970 g/ml; respectively), to give that the obtained droplets were of a mean diameter of 
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around 1 µm. As the droplets emerge, a substrate for sample collection was placed at a distance of 
around 3 cm to ensure the complete evaporation of water from the droplet that is assumed to happen 
in a fraction of time while flying in air. As the water in the droplet evaporates, the droplet shrinks in 
size resulting in the exposure of GO sheets to confining forces that compress sheets isotropically to 
compress them into a near-spherical particle like a crumpled paper ball [83]. Simulation provided by 
Chen Y et al. [90] showed that GO sheets diffuse to the droplet surface as solvent evaporates and then 
gets dragged inwardly as the droplet volume reduces during the drying process via a mechanism 
known as “cling and drag” mechanism.  
The extent of crumpling and the size of obtained crumpled particles can be tuned by the conformation, 
radius, concentration of the GO sheets within the droplet as well as their physical properties including 
their spring constant and Young’s modulus that is related to the sheets’ thickness. Last but not least 
the confining force applied to the sheets also influence the size of the crumpled particles and their 
degree of crumpling.  As an example, the higher the GO concentration within the droplet, the larger 
is the size of the crumpled particles and the lower is the degree of their crumpling. This results as high 
concentration will provide thicker flakes of higher bending modulus that are stiff to deform thus, 
providing less crumped large particles [83]. 
To determine the size and morphology of obtained CGO Transmission electron microscope (TEM) (Jeol 
1010 and Jeol 2010, Jeol, Tokyo, Japan) was used the first thing. A drop of sonicated GO sheets (as a 
control) and the mist of nebulized GO sheets were each placed and nebulized directly on a carbon-
coated copper grid; respectively and left to dry at room temperature. Then the samples were 
examined using TEM at an accelerating voltage of 80 kV.  
The hydrodynamic diameter and zeta potential of obtained CGO were then evaluated using Dynamic 
Light Scattering (DLS) and Laser Doppler Electrophoresis (LDE); respectively (Zeta sizer nano series 
(Nano ZS), Malvern Instruments Ltd., Worcestershire, UK). Zeta potential is determined via LDE by 
measuring the velocity of the particle moving in the suspending liquid when electrical field is applied. 
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Using the measured velocity together with the electric field applied, viscosity of the suspending liquid 
and the dielectric constant, the zeta potential of particles can be worked out. Whereas, the 
hydrodynamic diameter of particles is determined from their Brownian motion using DLS [125]. For 
DLS and LDE 1 ml of freshly atomized GO suspension was used. To validate reproducibility triplicate 
samples were analysed and the standard deviation (S.D.) value of the three was adopted.  
Raman spectroscopy was also used to confirm the maintenance of GO features after being nebulized. 
The sample was prepared via the nebulization of GO suspension on a clean silicon wafer and then left 
to dry in ambient air at room temperature. The Raman spectrum was then obtained using a Raman 
spectrometer (LabRAM HR Evolution, Horiba, Kyoto, Japan) with a 633 nm laser source at 1 mW 
power. Raman spectroscopy measurement is dependent on the inelastic Raman scattering of a 
monochromatic light from a laser source on the near ultraviolet, near infrared or visible range. The 
monochromatic light interacts with the molecular vibrations in the sample introduced. This interaction 
results in the energy of the laser photons to be shifting up or down. These shifts in the phonons’ energy 
provide information regarding the vibrational modes of the molecule under examination. By this 
Raman spectroscopy provides a structural fingerprint for each molecule to be easily identified [126, 
127]. 
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Figure 7. Schematic diagram of the setup used for nebulizing GO suspension and consequent collection for further 
analysis- Sonicated GO suspension of concentration 0.5 mg/ml is fed from the syringe using syringe pump at a 
rate of 50ml/hr. Through the syringe needle the GO suspension is fed at the focal point of the SAW device used 
with curved IDTs (30 MHz focus device). The suspension is fed to provide a thin layer on the top of the piezoelectric 
substrate (LiNbO3). Once power is applied to the IDTs, the SAWs travel from the curved IDTs to be focused at the 
focal point on the surface of the SAW device. At this point when the waves come in contact with the GO 
suspension and leak within the fluid. As the acoustic streaming overwhelms the capillary stress of the liquid, 
nebulization of GO suspension results. In this case the liquid bulk breaks into micro-sized droplets containing GO 
sheets. The droplets solvent (which is water in this case) evaporates in-flight resulting in the shrinkage of the 
droplet size inducing the crumpling of GO sheets in response to capillary compressive forces. The resulting mist 
was collected in either a closed system or on a substrate for further analysis. Collection took place at a distance 
of 3 cm to ensure complete solvent evaporation.  
2.2. Preparation and characterization of polyethyleneimine (PEI)-
functionalized CGO (CGO-PEI) 
GO sheets were functionalized with polyethyleneimine (PEI) based on the protocol described by Feng 
et al. [39]. Functionalization took place via the formation of amide linkage between PEI’s amine and 
GO’s carboxyl groups. This was achieved by using N-(3-Dimethylaminopropyl)-N’-ethyl carbodiimide 
hydrochloride (EDC) which is an amine-COOH cross linker as seen in Fig 8.  
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The procedure was as follows: 1 ml of 0.5 mg/ml EDC was added to 1 ml of 0.5 mg/ml GO sheets 
suspension and stirred for 10 mins at room temperature. Followed by the addition of 1 ml of 2.5 mg/ml 
PEI solution and left to stir for 5 mins before adding 3 ml of 0.5mg/ml EDC to the mixture. Then the 
mixture was left to stir overnight at room temperature. Consequently, it was washed three times with 
deionized (DI) water and functionalized sheets were collected by centrifugation eventually at 14 000 
rpm (Centrifuge 5430, Eppendorf, Hamburg, Germany).  
To confirm the amide linkage formation between GO and PEI, Fourier Transform-Infrared 
Spectrometer (FT-IR), (PerkinElmer, MA, USA) was used for analysis. FT-IR works by exposing the 
sample whether it is solid or liquid to a beam containing light of several frequencies. Then the amount 
of beam absorbed by the sample is determined at each wavelength of light. Since each bond in a 
molecule has different intensity and wavelength of light absorbance, FT-IR can be used to determined 
bond breaking and formation based on the peaks obtained for the sample [128].   
Then to estimate the PEI content in the GO-PEI product obtained, thermo-gravimetric analysis (TGA), 
(Pyris 1 TGA, Agilent, Santa Clara, CA, US) was utilized. TGA works by continuously measuring the mass 
of the sample as the temperature of the sample changes over time. To incur a thermal reaction, the 
temperature is usually elevated at constant rate. Then the collected thermogravimetric data is 
compiled into a plot of time or temperature on the x-axis versus the mass or percentage of initial mass 
on the y axis known as the TGA curve from which in-depth thermal analysis is obtained [129]. The 
analysis was performed by scanning the weight loss percentage (%) of solid GO-PEI from 25 to 800ᵒC 
under nitrogen gas at a heating rate of 10ᵒC min-1. The concentration of GO in the obtained suspension 
was determined using UV-Vis Spectrophotometer to determine GO to PEI weight ratio in 1ml.  
The PEI-functionalized GO sheets were nebulized using SAW platform in the same manner mentioned 
earlier for preparing CGO, to obtain CGO-PEI. To study the effect of GO functionalization with PEI, the 
zeta potential, size and morphology of obtained CGO-PEI were characterized using LDE, DLS and TEM; 
respectively. For DLS and LDE triplicate samples were analysed and the S.D. value of the three was 
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adopted to validate the procedure’s reproducibility. Raman spectroscopy has also been used to ensure 
maintenance of GO Raman characteristics after being functionalized with PEI. 
<Image removed due to copyright restrictions> 
Figure 8. EDC (carbodiimide) cross-linking reaction scheme- EDC will work by activating carboxylic group of GO 
forming active ester which upon PEI addition will allow the formation of amide bond. The Figure is retrieved from 
Figure 5 in Hayworth, D. Carbodiimide Crosslinker Chemistry. Retrieved, November 2017. 
2.3. CGO-cell interaction  
2.3.1. Cell cultivation  
A549 cells were cultivated in phenol red free DMEM (Dulbecco’s modified Eagle’s culture medium) 
with L-Glutamine media supplemented with 10 % FBS and 1 % Pen-Strep antibiotic in 5 % CO2-
incubator at 37°C.  
2.3.2. Extent of CGO and CGO-PEI uptake determination  
2.3.2.1. MTT assay  
It is important to study the effect of prepared particles on cell viability and proliferation to determine 
the cellular response to external factors. Examining cell proliferation via tetrazolium salts reduction is 
a widely accepted and a reliable method. Usually metabolically active cells reduce yellow tetrazolium 
MTT into purple formazan crystals that can be released from inside the cells upon solubilization by 
DMSO. Then the solubilized formazan crystals are quantified spectrophotometrically. The absorbance 
for dead cells will be lower comparatively to viable cells. As a result, the linear relationship between 
signal produced and cell number is established; providing an accurate quantification of alteration in 
the rate of cell proliferation [130]. 
For the MTT toxicity assay, A549 cells were plated in 96-well F-bottom cell culture plates in which 
20x103 cells/ well were plated. Different concentrations of CGO and CGO-PEI (7.5, 15, 30, 60 and 120 
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μg/ml) were added to cells. The different concentrations were calculated based on the concentration 
of GO that has been determined via the UV-Vis Spectrophotometer. Quadruplets were assigned for 
each concentration and the arithmetic mean was eventually adopted. Untreated cells were used as 
controls and absorbance values at λ= 570 nm for those cells were considered as 100 % viability. Cells 
were incubated with particles for 24 hrs. Following incubation, cells were washed with Phosphate 
Buffered Saline (PBS) and 3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT) of 
concentration 0.5 mg/ml was added and followed by 2 hrs of incubation. MTT was then replaced with 
Dimethyl sulfoxide (DMSO) and the plate was thoroughly mixed in a shaking incubator for 1 hr. Finally, 
absorbance of wells was measured using plate reader (SpectraMax Paradigm, Multi-Mode Detection 
Platform, Molecular devices, Sunnyvale, CA, US) at λ= 570 nm. Cell viability for each GO concentration 
for CGO and CGO-PEI was then determined relative to control. The toxicity effect of same 
concentrations of GO and GO-PEI sheets that have not been atomized (i.e. not crumpled) were studied 
as well on A549 cells. 
2.3.2.2. Effect of CGO concentration and functionalization on the cells’ uptake 
magnitude  
CGO and CGO-PEI were used to study the efficiency of cellular uptake in A549 cells. Suspensions of GO 
and GO-PEI were nebulized in a closed system as mentioned previously. Then the GO concentration 
of collected mist was determined using UV-Vis spectrophotometer. Consequently, same 
concentrations used for MTT assay were used to confirm efficient cell uptake (7.5, 15, 30, 60 and 120 
µg/ml). For this purpose, cells were seeded at a density of 3x105 cells/well in 24-well F-bottom cell 
culture plates. Different concentrations of CGO and CGO-PEI were added to A549 cells and incubated 
for 24 hrs. For each concentration, quadruplets were assigned, and the arithmetic mean was 
eventually adopted. After 24 hrs, cells were washed with PBS. Confirmation of cellular uptake as well 
as studying the effect of increased concentration added were determined via studying the side 
 27 
 
scattering of cells in comparison to untreated cells (control) using flow cytometer (Accuri, BD 
Biosciences, Franklin Lakes, NJ, US). 
2.4. Statistical analysis: 
Statistical analysis of data was performed with one-way analysis of variance (ANOVA) using Design-
Expert® Software (Stat-Ease, Inc., USA). P-values less than 0.05 were considered significant. 
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Chapter 3: Results 
1. CGO preparation and characterization  
CGO were prepared via nebulization platform using SAWs. Crumpling of the GO sheets was dependent 
on the evaporation of solvent from droplet produced upon nebulization via capillary compressive 
forces. First, the obtained product was characterized for its morphology to ensure the production of 
CGO as aimed. For morphology characteristics, TEM was used with approximate indication of the 
particle size range and to compare it with un-atomized sonicated GO sheets. TEM images show 
crumpled GO sheets with internal folds and wrinkles have been obtained upon nebulization via SAW 
(Fig 9b) in contrast to just sonicated sheets (Fig 9a) where a flat sheet is seen. This indicates the success 
of using SAWs to produce CGO without the need for being exposed to elevated temperatures. The 
obtained CGO found to be in the nano-size range. DLS and LDE measurements (Fig 9c and d) showed 
that the CGO obtained were of an average hydrodynamic diameter and a zeta potential of 307.5±11.8 
nm and -41.2±2.6 mV; respectively. The negative zeta potential provided by the LDE measurement 
(Fig 9d), is believed to be originating from the oxygen-containing functional groups such as hydroxyl, 
epoxy and carboxyl groups decorating the surface of GO sheets [131, 132]. 
 29 
 
 
2. Preparation and characterization of CGO-PEI  
After functionalizing GO with PEI, FT-IR was used to examine the amide bond formation between the 
carboxyl groups of GO and the amino groups of PEI. The FT-IR peaks for GO-PEI were compared with 
those of GO. Fig 10a shows the FTIR spectra of GO and GO-PEI, where significant difference can be 
observed. 
Figure 9. TEM images of sonicated GO sheets (a) before and (b) after nebulization via SAW, (c and d) Size distribution and zeta 
potential of CGO; respectively. 
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Figure 10. (a) FT-IR spectra of GO, PEI and GO-PEI showing amide bond formation upon the functionalization of 
GO with PEI and (b) TGA Curves of GO and GO-PEI. 
The chart obtained (Fig 10a) showed that in comparison to GO, GO-PEI possessed peaks at 2939 cm-1 
and 2820 cm-1 corresponding to the symmetry and anti-symmetry stretching vibration absorption 
peaks of -CH2- groups related to the PEI. As well as the appearance of peaks at 1580 cm-1 and 1457 
cm-1 which correspond to the bending vibration of N-H group and the stretching vibration of C-N group 
in PEI reflects the introduction and coverage of PEI to the GO sheets. Moreover, the chart for GO-PEI 
shows that the characteristic GO peaks at 1720 cm-1 and 1377 cm-1 corresponding to the stretching 
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vibration of C=O and O-H groups; respectively in the carboxylic moiety of GO have disappeared and 
weakened in intensity; respectively. This infers that most of the carbonyl moieties in GO have been 
converted to amides. These changes in FT-IR spectra confirm the presence of PEI on the GO surface 
and furthermore, some of them are covalently linked to the GO surface by amide bonds [51, 133-135]. 
Same peaks were obtained for CGO-PEI (chart not shown).  
After confirming the success of GO functionalization with PEI, TGA was utilized consequently to 
determine the PEI content in the GO-PEI product. Fig 10b shows the TGA curves for both the GO and 
GO-PEI. From the plotted curves it can be visualized that GO is thermally unstable and its mass loss at 
around 233.5ᵒC was about 36%, which can be ascribed to the decomposition of labile oxygen-
containing functional groups. Compared with GO, GO-PEI shows a smaller mass loss at around 204.9ᵒC 
of about 18%, indicating the slight reduction of GO during the introduction of PEI, which is in 
accordance with the FT-IR results. PEI is a high-molecular weight polymer with a degradation 
temperature between 240 and 310ᵒC. Thus, the second weight loss observed for the GO-PEI at 293-
450ᵒC of about 41% could primarily be originating from the thermal decomposition of PEI and the 
further reduction of GO. Deducting the total amount lost by GO the PEI weight loss contributes to 23% 
[134, 135]. 
Functionalized GO sheets with PEI were then nebulized using same procedure used for GO sheets. 
TEM images were taken to look at the structure of the product obtained. From Fig 11a it can been 
seen that crumpled structure is maintained of approximately the same size range provided by 
crumpling GO sheets. DLS of CGO-PEI has shown to provide unimodal size distribution of average 
hydrodynamic diameter of 281.9±23.3 nm (Fig 11b) and zeta potential of 43.9±3.2 mV (Fig 11c).  
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Figure 11. (a) TEM image of CGO-PEI (b and c) Size distribution and zeta potential of CGO-PEI after nebulization. 
For carbonaceous materials, Raman spectroscopy is considered a powerful tool for their 
characterization. Thus, to ensure maintenance of GO features after nebulization via SAWs and 
functionalization with PEI, Raman spectroscopy was used. The Raman spectra of CGO and CGO-PEI 
obtained (Fig 12) show two peaks at 1339 and 1609 cm-1 for CGO, 1335 and 1599 cm-1 for CGO-PEI; 
respectively where each peak corresponds to sp3 carbon atoms of the defect structure (D-band) and 
sp2-hybridized carbon atoms from the aromatic structure of GO (G-band); respectively [136, 137]. By 
calculating the ID/IG ratio for each spectrum the ratio for CGO-PEI which is 1.37 is higher than that of 
CGO which has a value of 1.19 indicating increase in the defect on the carbon skeleton from 
functionalization with PEI.  
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Figure 12. Raman spectra for CGO and CGO-PEI. 
3. CGO and CGO-PEI-cell interaction  
3.1. MTT assay 
Using standard solutions of GO with the following concentrations: 2.5, 5, 10 and 20 µg/ml, the 
concentration of obtained CGO was determined using UV-Vis Spectrophotometer. Consequently, the 
cytotoxicity of CGO, CGO-PEI, PEI, un-atomized GO and GO-PEI sheets were evaluated for A549 cells 
using MTT assay as shown in Fig 13. In Fig 13, GO started to show a significant decrease in cell viability 
at concentration of 120 µg/ml, where it reached to ~87% for both crumpled GO and GO sheets; 
respectively in comparison to the initial concentration added (which is 7.5 µg/ml). However, the CGO-
PEI did not show any decrease in cell viability at any concentration in comparison to the un-atomized 
GO-PEI sheets, which showed a significant lowering of cell viability at the concentration of 30 µg/ml 
and further decrease to ~70% upon the increase of GO-PEI concentration added. Whereas, equivalent 
concentrations of PEI (equivalent to the amounts associated with GO in GO-PEI samples) separately 
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examined on A549 cells showed an extremely significant decrease in cell viability reaching to ~56% at 
concentration of 18 µg/ml with further decrease to ~27% and ~18% as the concentration of PEI 
increased to 36 and 72 µg/ml; respectively.  
 
3.2. Effect of CGO and CGO-PEI concentration and functionalization on the 
cells’ uptake magnitude 
To ensure that cellular uptake of CGO and CGO-PEI took place in A549 cells, same concentrations of 
CGO and CGO-PEI were added to the cells and the cellular uptake was determined by the side 
scattering (SSC) of light using flow cytometry. The side scattered light is usually measured at a 90ᵒ 
angle which correlates to the degree of intracellular granularity. This degree of granularity 
corresponds to the concentration of nanoparticles uptaken by the cells [138-141].  By plotting Mean 
Figure 13. MTT assay of (a) un-atomized GO and GO-PEI sheets, (b) PEI and (c) CGO and CGO-PEI on A549 cells. The decrease in 
cell viability at the high concentration of GO (120 µg/ml) is statistically significant for both crumpled GO and un-atomized GO 
sheets (*P<0.05 for n=4 and **P<0.01 for n=4; respectively) on A549 cell lines. The un-atomized GO-PEI sheets show significant 
reduction in cell viability by the concentration of 30 µg/ml (*P<0.05 for n=4). As for the PEI, highly significant decrease in cell 
viability was obvious at the concentration of 18 µg/ml (****P<0.0001 for n=4). 
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side scattering (SSCA) versus different concentrations of GO added to A549 cells, the chart in Fig 14 
was obtained. The chart shows that the cellular uptake increased with increasing the added 
concentrations of CGO-PEI particles. It could be determined from the clear increase in side scatter of 
the nuclei from CGO-PEI-treated cells. The mean distribution of side-scattered light is increasing in a 
linear-dependent fashion with increasing mass concentrations, indicating the uptake of all particles 
added reaching a state of saturation by the concentration of 120 µg/ml. On the other hand, CGO did 
not show any significant cellular uptake till a high concentration of 120 µg/ml was added. CGO-PEI at 
the highest concentration added (120 µg/ml) show significantly higher cellular uptake in comparison 
to CGO of the same concentration.  
 
Figure 14. Estimate of A549 cellular uptake after 24hrs exposure to different concentrations of CGO and CGO-PEI 
assessed by monitoring the mean SSCA of A549 cells in flowcytometry. It is statistically significant that the 
concentration of uptaken CGO-PEI by the cells increased with increasing the concentration added (****P<0.0001 
for n=4). However, the uptake of CGO only showed significant increase at concentration of 120 µg/ml 
(****P<0.0001 for n=4). 
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Chapter 4: Discussion 
1. Preparation and characterization of CGO and CGO-PEI 
Nebulizing GO sheets using SAW resulted in the crumpling of flat sheets of size 1 µm (Fig 9a) to a ball-
like structure with internal wrinkles and folds of a size 300 nm (Fig 9b). This means that the SAW 
platform was successfully able to produce CGO upon solvent evaporation of the micron and 
submicron-sized droplets emerging from the nebulization [111]. The CGO were generated in response 
to capillary compressive force applied with droplet size shrinkage. The SAW platform has shown the 
ability to provide CGO without the aid of heat. Not only it could provide CGO, but also they were of a 
nano-size range that is acceptable for cell uptake as determined from the TEM and DLS measurements 
[142].  
After determining the success of SAW platform in providing nano-sized range CGO without the aid of 
heat, it was functionalized with PEI to enhance its cellular uptake for therapeutic delivery purposes. 
GO was functionalized with PEI via amide bond formation using EDC linker and then was examined 
using the FT-IR which has shown that GO sheets have been successfully covered with PEI. The success 
of functionalization has also been proven with the shift of the CGO zeta potential from -41.2±2.6 mV 
to 43.9±3.2 mV, indicating that all oxygen-containing groups of GO sheets are covered with amino 
groups of PEI contributing to the positive potential provided. This shift in potential is preferable for 
adequate cellular uptake to use CGO-PEI as a drug delivery platform [48, 143]. It was found also that 
the functionalization of GO with PEI induced further reduction in size of obtained CGO. The mean 
hydrodynamic diameter of particles was reduced from 307.5 nm to 282 nm.  The reduction in size is 
believed to be attributed to PEI functionalization in which electrostatic interaction between the amino 
group of branched PEI and the remaining oxygen-containing functional groups that did not get 
involved in the amide linkage such as the hydroxyl groups. This could have resulted in further 
crumpling of GO to obtain particles of smaller and narrower size distribution [144, 145]. 
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Last but not least, Raman spectra (Fig 12) has shown that nebulization of GO sheets and functionalizing 
them has not affected the main characteristics of GO sheets (D and G bands) only the increase in ratio 
of D-band intensity to that of G-band for CGO-PEI proved the success of GO-functionalization with PEI. 
The increase in ID/IG ratio from 1.19 for CGO to 1.37 for CGO-PEI reflects the removal of oxygen-
containing functional groups and the conversion of sp3 carbon to sp2 carbon in GO’s carbon skeleton 
upon polymer functionalization. This change is attributed to the nucleophilic addition of amino groups 
of PEI to the epoxy groups of the GO forming a covalent bond [136, 146-148].  
Thus, SAW platform was able to provide nano-sized CGO-PEI that is suitable for cellular-therapeutic 
delivery in the absence of external heat that might affect the integrity of thermolabile or biological-
based therapeutics. Moreover, this platform has not affected GO sheets’ characteristics which is 
important as it might affect its unique properties including thermal and optical properties that could 
be used in the future to add more therapeutic and diagnostic features via thermal ablation and 
bioimaging; respectively [89, 103, 149].  
2. CGO and CGO-PEI-cell interaction 
From Fig 13 it can be seen that the GO sheets and CGO started to reduce cell viability at a 
concentration of 120 µg/ml, which was the same concentration at which significant cellular uptake 
was obvious (Fig 14). This could be a result of GO affecting the cellular properties via activating 
apoptotic pathway and generating reactive oxygen species (ROS) [60]. Since GO is negatively charged 
it enters the cells via endocytosis pathway which is concentration-dependent [150, 151]. Cancer cells 
are usually highly negatively charged due to the presence of high content of phosphatidylserine (PS) 
and O-glycosylated mucines which are high molecular weight glycoproteins [76, 77, 152-156]. 
Accordingly, we could only observe the reduction in cell viability significantly when a high 
concentration (120 µg/ml) of GO whether sheet or crumpled was added which coincides with results 
published previously [76, 77, 157]. 
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On the other hand, CGO-PEI at the same concentrations of GO did not show any significant change in 
cell viability even at concentration of 120 µg/ml (Fig 13c). GO-PEI did not follow the same pattern, at 
concentration of 30 µg/ml a decrease in cell viability was noticed. Cytotoxicity was even visualized as 
the concentration increased to 60 and 120 µg/ml, where the cell viability was reduced significantly to 
~70% (Fig 13a). This can be related to the increase the amount of PEI to which the cells were exposed. 
Since constant mass of PEI is attached to GO sheets (as determined from TGA), increasing the GO 
concentration added to cells will increase the concentration of PEI to which cells are exposed. This 
coincides with the results obtained for PEI (Fig 13b), in which cytotoxicity was observed at 
concentration of 18 µg/ml which is the same concentration accompanying 30 µg/ml of GO. The cell 
viability decreased significantly to reach ~56% at this concentration with further decrease to ~27% 
and ~18% as the concentration of PEI increased to 36 and 72 µg/ml. These are the concentrations 
equivalent to PEI concentration associated with GO concentrations 60 and 120 µg/ml at which evident 
cytotoxicity was observed. This cytotoxicity of GO-PEI is based from PEI-mediated cell membrane 
interaction that may result in hole formation leading to membrane thinning and erosion that results 
eventually in cell apoptosis [73, 158].  
However, when GO-PEI was crumpled, its cytotoxicity on A549 cells was absent for all examined 
concentrations. Though they were the same GO-PEI sheets used as for the un-atomized samples i.e. 
have the same PEI content, same concentrations did not have cytotoxic effect on cells. This could be 
due to the crumpling of the GO-PEI sheets that lowered the percentage of PEI exposed to the cells, as 
some of the functionalizing PEI could be internalized within the folds and wrinkles of crumped GO. 
This means that lower content of PEI interacted with cell membrane to induce toxicity. According to 
our knowledge, this is the first time to record a high cell viability at such high concentration of GO-PEI 
samples functionalized with branched PEI of high molecular weight (25 KDa). Published studies 
regarding GO-PEI sheets showed cell viability of ~80% at concentration of about 10 µg/ml (based on 
PEI) and the viability of cells beyond this concentration was not examined [39, 47, 48].  
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This indicates that combining PEI with GO has helped to reduce PEI’s toxicity on cells as well as 
crumpling sheets into ball-like structure has lowered the toxicity even more by significantly elevating 
cell viability from ~18% and ~70% to ~97% in comparison to PEI and GO-PEI sheets; respectively at 
their highest concentrations (72 and 120 µg/ml; respectively). This could be the result of lowering the 
density of cationic residues interacting with the cells [55]. Thereby, allowing the cellular uptake of 
large concentration of GO-PEI prepared from high Mwt PEI in the absence of associated cytotoxicity. 
In this case it will not be necessary to sacrifice the efficiency of the nanotherapeutic delivery platform 
through the usage of low molecular weight and linear PEI that are of less efficient transfection ability 
as well as loading capacity as a substitute to avoid unnecessary cytotoxicity [159-163]. At the same 
time, functionalizing GO with PEI has enhanced GO’s cellular uptake significantly by 1.5 times as being 
positively charged since it can interact favourably with negatively charged cell surface especially with 
cancer cells [47, 49, 143, 164].  
Thus, CGO-PEI, a nanotherapeutic delivery platform that is of efficient cellular uptake and negligible 
cytotoxicity has been developed using SAW platform. Such delivery platform allows concomitant 
encapsulation of biological-based and thermolabile therapeutics for cellular delivery, as the 
manufacturing procedure does not expose the therapeutic material to harsh conditions including high 
temperature and low frequency ultrasonic waves.   
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Conclusions and Future Perspectives 
In conclusion, SAW has shown that it has the capability of producing nano-sized range CGO-PEI in one 
step that is acceptable for cell uptake. Functionalizing GO with PEI as an example of a cationic polymer 
has enhanced GO’s uptake by about 1.5 times. PEI cytotoxicity effect has been reduced with two 
factors; combining it with GO and crumpling the complex. Both factors have helped in reducing the 
cationic residues density getting in contact with the cell thus, lowering the cytotoxicity potential. In 
comparison to CGO, CGO-PEI had a better cell viability of ~97% even with high concentration of 120 
µg/ml. According to our knowledge this first time to obtain such reduced cytotoxicity with high Mwt 
PEI. These results indicate the success of generating a nanotherapeutic platform of efficient cell 
uptake and reduced cytotoxicity for the encapsulation and delivery of biologically-based therapeutics 
such as genes.  
In the future, the encapsulation efficiency of CGO-PEI for biologically-based therapeutics such as siRNA 
should be studied to provide siRNA-loaded CGO-PEI via one step SAWs platform to be used in gene 
therapy to treat cancer and other generic disorders. The transfection efficiency of prepared CGO-PEI 
from 25 KDa PEI should be studied and compared with other CGO-PEIs prepared with PEI of different 
Mwts in addition to their cytotoxicity.  Due to the unique features associated with GO specifically, the 
optical features, CGO-PEI obtained via SAW nebulization can be used to deliver the siRNA or any other 
biological therapeutics while allowing the tracking of cellular uptake and visualizing the therapeutic 
efficiency of delivered therapeutics on cells especially if combined with inorganic nanoparticles. 
Further experiments should be done to study the effect of changing the concentration and size of GO 
sheets on the degree of crumpling and size of obtained CGO to be able to manipulate size of obtained 
particles for various applications. Properties whether electrical or optical for the CGO obtained via 
SAWs platform should be studied and compared with those published.    
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